Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA/REIPI cohort

Transplantation

Volumn 92, Issue 5, 2011, Pages 543-549

  López Medrano, Francisco ^a   Fernández Ruiz, Mario ^a   Morales, José María ^a   San Juan, Rafael ^a   Cervera, Carlos ^b   Carratalá, Jordi ^c   Torre Cisneros, Julián ^d   Gavaldá, Joan ^e   Muñoz, Patricia ^f   Len, Óscar ^e   Martín Dávila, Pilar ^g   Ramos, Antonio ^h   Montejo, Miguel ⁱ   Lumbreras, Carlos ^a   Moreno, Asunción ^b   Aguado, José María ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ HOSPITAL DE CRUCES   (Spain)

Author keywords

Bloodstream infection; Hepatitis C virus; Infection; Kidney transplantation; RESITRA REIPI

Indexed keywords

HEPATITIS C ANTIBODY; OKT 3; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; BACTERIAL INFECTION; BLOODSTREAM INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; INFECTION RATE; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RETRANSPLANTATION; RISK FACTOR; SPAIN; URINARY TRACT INFECTION;

ADULT; AGED; COHORT STUDIES; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFECTION; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEPSIS; SPAIN; URINARY TRACT INFECTIONS;

EID: 80052394261     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318225dbae     Document Type: Article

References (23)

1. Domínguez-Gil B, Morales JM. Transplantation in the patient with hepatitis C. Transpl Int 2009; 22: 1117.
2. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001; 38: 919.
3. Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation 2004; 78: 745.
4. Fabrizi F, Martin P, Dixit V, et al. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 1452.
5. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667.
6. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257.
7. Rao KV, Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765.
8. Pedroso S, Martins L, Fonseca I, et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc 2006; 38: 1890.
9. Corell A, Morales JM, Mandroño A, et al. Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet 1995; 346: 1497.
10. Micheloud D, Salcedo M, Bañares R, et al. High rate of infection and immune disorders in patients with hepatitis C virus after liver transplantation. Transpl Infect Dis 2009; 11: 367.
11. Morales JM, Marcén R, Andres A, et al. Renal transplantation in patients with hepatitis C virus antibody. A long national experience. NDT Plus 2010; 3(suppl 2): ii41.
12. Iwaki Y, Cecka JM, Terasaki PI. The transfusion effect in cadaver kidney transplants: yes or no. Transplantation 1990; 49: 56.
13. Fortun J, Martin-Davila P, Pascual J, et al. Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis 2010; 12: 397.
14. Morales JM, Campistol JM, Domínguez-Gil B, et al. Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients. Am J Transplant 2010; 10: 2453.
15. Pereira BJ, Wright TL, Schmid CH, et al. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799.
16. Reddy S, Sullivan R, Zaiden R, et al. HepatitisCinfection and the risk of bacteremia in hemodialysis patients with tunneled vascular access catheters. S Med J 2009; 102: 374.
17. Linares L, Cervera C, Cofán F, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007; 39: 2222.
18. San Juan R, Aguado JM, Lumbreras C, et al. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant 2007; 7: 964.
19. San Juan R, Aguado JM, Lumbreras C, et al. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis 2008; 47: 875.
20. Snyder JJ, Israni AK, Peng Y, et al. Rates of first infection following kidney transplant in the United States. Kidney Int 2009; 75: 317.
21. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128.
22. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7.
23. Torre-Cisneros J, Fortún J, Aguado JM, et al. [Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients.] Enferm Infecc Microbiol Clin 2005; 23: 424.